FDA Participates in Int'l Internet Week to Combat Counterfeit Medicines
The Food and Drug Administration has announced that it and other regulatory and international partners have completed the International Internet Week of Action (IIWA), a cooperative effort to curb online sales and distribution of counterfeit and illegal medical products.This year’s IIWA, called Operation Pangea IV, focused on websites supplying illegal and dangerous medicines (such as drugs containing human growth hormone (HGH), sildenafil citrate, or isotretinoin), and ran from September 20-27, 2011.
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
The FDA states that it sent Warning Letters to the operators of the identified websites, all of which appear to be associated with the same individuals and corporate entities located outside of the U.S. In addition, the agency sent notices to the Internet Corporation for Assigned Names and Numbers, Registries, Internet Service Providers (ISPs), and Domain Name Registrars (DNRs) informing them that these websites were selling products in violation of U.S. law.
World Customs Organization release on international event available here.